Following a number of obstacles, the shingles vaccine Zostavax, which was developed by Merck, was recently approved for sale on the Danish market.
The vaccine, which as registered in 2006 but did not come to market due to limited production capacity, is approved for patients over the age of 50 to prevent shingles, also known as zoster or herpes zoster.
Most parents see vaccinations as a medical necessity to protect their children from what are now preventable diseases, including measles, mumps, rubella, whooping cough and chicken pox. Others are steadfast in their belief that vaccinations are a danger to their children, and choose not to immunize them. In fact, a study published in the journal Pediatrics showed that 1 in 10 parents in the United States now forgo or delay vaccinations for their kids.
"The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 to respond promptly, efficiently, and with scientific rigour to vaccine safety issues of potential global importance.
The Committee provides independent, authoritative, scientific advice to WHO on vaccine safety issues of global or regional concern with the potential to affect in the short or long term national immunization programmes."